Cubist Systematic Strategies’s ARS Pharmaceuticals SPRY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-77,162
| Closed | -$423K | – | 2766 |
|
|
2023
Q4 | $423K | Buy |
+77,162
| New | +$423K | ﹤0.01% | 1402 |
|
|
2023
Q2 | – | Sell |
-35,114
| Closed | -$229K | – | 2965 |
|
|
2023
Q1 | $229K | Sell |
35,114
-28,966
| -45% | -$189K | ﹤0.01% | 2161 |
|
|
2022
Q4 | $547K | Buy |
+64,080
| New | +$547K | ﹤0.01% | 2136 |
|
|
2022
Q3 | – | Sell |
-14,159
| Closed | -$60K | – | 3873 |
|
|
2022
Q2 | $60K | Sell |
14,159
-22,122
| -61% | -$93.7K | ﹤0.01% | 3528 |
|
|
2022
Q1 | $127K | Sell |
36,281
-8,293
| -19% | -$29K | ﹤0.01% | 3156 |
|
|
2021
Q4 | $297K | Sell |
44,574
-12,480
| -22% | -$83.2K | ﹤0.01% | 2806 |
|
|
2021
Q3 | $569K | Buy |
57,054
+56,981
| +78,056% | +$568K | 0.01% | 1946 |
|
|
2021
Q2 | $2K | Buy |
+73
| New | +$2K | ﹤0.01% | 2888 |
|